Skip to main content
. Author manuscript; available in PMC: 2011 Feb 15.
Published in final edited form as: Cancer. 2010 Feb 15;116(4 Suppl):1067–1074. doi: 10.1002/cncr.24794

Figure 4.

Figure 4

Results of LDH assay of CasKi cells treated with various concentrations of: a) anti-E6 C1P5 mAb; b) control ch-TNT3 mAb. Control–no antibody was added to the cells; max lysis the cells were treated with lysis buffer. Treatment with unlabeled anti-E6 C1P5 mAb causes cell death in CasKi cells.